Patient Journey

Build Products Aligned to the Realities of Care Delivery

Patient journey mapping at Cetas Healthcare

We help you answer critical questions such as:

Where does the patient first enter the care pathway, and what drives referrals?

Which clinical bottlenecks delay diagnosis or treatment decisions?

How do physicians select therapies, devices, or interventions at each stage?

What structural, reimbursement, or policy barriers impact the uptake of new technologies?

How Cetas Healthcare Performs Patient Journey Research

01

Patient Flow & Experience Dynamics

We map every stage of the care process—from symptom recognition to long-term follow-up—capturing:

  • Points of delay or misdiagnosis
  • Emotional and informational barriers
  • Variability in referral pathways
  • Experience gaps across clinical and non-clinical touchpoints
02

Experience gaps across clinical and non-clinical touchpoints

We examine what shapes clinician choices throughout diagnosis and treatment, including:

  • Referral triggers and staging workflows
  • Treatment selection criteria across patient profiles
  • Barriers to adopting new therapies or technologies
  • Variations across specialties and practice settings
03

Care Delivery Infrastructure & System Capacity

We assess how the healthcare environment influences patient outcomes, analyzing:

  • Availability of diagnostic and procedural capabilities
  • Resource differences across high- and low-capacity settings
  • Impact of staffing, equipment, and facility type
  • Operational bottlenecks affecting patient flow
04

Economic & Reimbursement Influences on Access

We evaluate the financial pressures shaping therapy uptake and continuity of care:

  • Insurance coverage limitations and reimbursement structures
  • Coding pathways and payer decision logic
  • Out-of-pocket costs and affordability barriers
  • Policy shifts impacting treatment decision patterns
05

Guideline, Policy & Market Evolution

We identify macro-level forces that reshape care delivery models, including:

  • Updates to national or specialty-specific treatment protocols
  • Adoption of digital health and emerging technologies
  • Shifts in screening, monitoring, and referral practices
  • Broader societal, regulatory, or healthcare ecosystem trends
06

Insight Generation & Strategic Translation

Our methodology blends qualitative depth with quantitative validation, supported by:

  • Interviews across patients, specialists, PCPs, nurses, and administrators
  • Real-world mapping of care patterns across geographies
  • Structured assessment of unmet needs, barriers, and opportunity areas
  • Frameworks that translate stakeholder insights into strategic recommendations

Case Studies

Care Pathway Research in Cardiology
Research in Cardiology

Care Pathway Research in Cardiology

Using qualitative and quantitative research with cardiology specialists across the US and Europe, we identified key challenges, unmet needs, and future technology priorities across the cardiology care pathway. The insights guided the client’s strategic planning... Read More

Delivered robust market size and growth projections for GI-ET procedures and devices

Have a Business Enquiry?

Contact Our MedTech Experts

NewsletterCetas RegPulse
Certification 1ISO 9001ISO 14155GDPR

Cetas Healthcare is the world’s leading boutique MedTech market research firm. We blend agency-grade research with strategic intelligence frameworks to track pipelines, regulatory shifts, clinical trials, and GTM strategies. As pioneers of ISO 14155-compliant PMCF surveys, we’ve managed 25,000+ patient case forms for Class II & III devices, helping clients secure CE certifications and stay ahead of EU MDR requirements.